NEWS

BerGenBio enters collaboration with MSD
Oslo Cancer Cluster member BerGenBio enters collaboration with MSD focused on clinical evaluation of BGB324 in combination with KEYTRUDA® (pembrolizumab) in advanced lung and breast cancer.

We are hiring an EU Advisor
We are currently looking for an EU advisor with skills and experience in writing EU funding proposals. This is a fixed term contract with duration to the end of 2018.

Three new members in Oslo Cancer Cluster
IRW Consulting, Eisai and Personalis, Inc. are all new members of the Oslo Cancer Cluster. Please read more about them here.

Kronikk i Aftenposten: De nordiske landene kan gjøre noe resten av verden drømmer om
De nordiske landene bør samarbeide mer for å utvikle bedre…

Targovax to present at upcoming conferences
Oslo, Norway, 6 March 2017: Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target, primarily, treatment-resistant solid tumors, announces that members of its senior management will present at the following life sciences and investor conferences:
- 10th European Life Science CEO Forum
- Redeye - Fight Cancer Seminar
- 11th Annual BIO-Equity Spring 2017 Conference

– Join our online communities
Oslo Cancer Cluster has a new Head of Communications. She wants to help you reach out.

Podcast on cancer research and development
Oslo Cancer Cluster member Radium Hospital Research Foundation, Radforsk, has launched their own podcast. The podcast is named Radium, and is about cancer research and development of new cancer treatments, as well as updates on Radforsk´s portfolio companies.

Targovax ASA: Fourth quarter and full year 2016 results
Oslo, Norway, 16 February 2017 - Targovax ASA ("Targovax" or "the Company"; OSE: TRVX), a clinical stage company focused on developing immuno-oncology therapies to target solid tumors, today announces its fourth quarter and full year 2016 results.
A meeting for investors, analysts and press will take place in Oslo today at 10:00 CET and a conference call will take place at 14.00 CET (details below).

Apply now for Startup Slam at BIO-Europe Spring!
Are you a startup or entrepreneur in Healthcare or Life-Sciences? If yes - keep reading!